Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$53,979,152
+$18,612,156 QoQ
Shares Held
45,004
+17.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#528
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $192,517,114 across 15 Drug Manufacturers - General names. LLY ranks #1 (28.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
45,004 | $53,979,152 | |
| 2 | JNJ |
Johnson & Johnson
|
142,327 | $36,146,788 | |
| 3 | ABBV |
AbbVie Inc.
|
92,109 | $23,178,308 | |
| 4 | MRK |
Merck & Co., Inc.
|
155,898 | $20,032,893 | |
| 5 | AMGN |
Amgen Inc
|
38,445 | $13,921,703 | |
| 6 | AZN |
Astrazeneca PLC
|
66,437 | $12,597,783 | |
| 7 | NVS |
Novartis AG
|
44,930 | $7,041,429 | |
| 8 | SNY |
Sanofi
|
159,361 | $6,798,340 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,979,152 | 45,004 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $35,366,996 | 38,452 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $38,656,243 | 35,970 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $23,813,993 | 31,211 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $25,521,032 | 32,739 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $22,802,549 | 27,609 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $20,103,652 | 26,041 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $22,443,518 | 25,333 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $43,393,958 | 47,929 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $37,501,561 | 48,205 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $26,909,918 | 46,164 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $24,732,150 | 46,045 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,888,768 | 53,070 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,825,215 | 51,905 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,620,477 | 45,431 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||